참고문헌 (43)

1. Nat Med Dowsett 8 1341 2002 10.1038/nm1202-1341 Breast cancer: aromatase inhibitors take on tamoxifen 

   상세보기

2. Nature Shaw 441 424 2006 10.1038/nature04869 Ras, PI(3)K and mTOR signalling controls tumour cell growth 

   상세보기

3. Mod Pathol Shoman 18 250 2005 10.1038/modpathol.3800296 Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen 

   상세보기

4. Mol Cancer Ther Clark 1 707 2002 Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells 

   상세보기

5. Endocr Relat Cancer Yu 8 249 2001 10.1677/erc.0.0080249 mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer 

   상세보기

6. Cancer Res Saal 65 2554 2005 10.1158/0008-5472-CAN-04-3913 PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma 

   상세보기

7. Nature Simoncini 407 538 2000 10.1038/35035131 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase 

   상세보기

8. J Clin Invest Miller 120 2406 2010 10.1172/JCI41680 Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer 

   상세보기

9. Oncogene Chen 21 4921 2002 10.1038/sj.onc.1205420 Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera 

   상세보기

10. J Biol Chem Campbell 276 9817 2001 10.1074/jbc.M010840200 Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance 

    상세보기

11. Science Kato 270 1491 1995 10.1126/science.270.5241.1491 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase 

    상세보기

12. Biol Reprod Smith 58 627 1998 10.1095/biolreprod58.3.627 Cross-talk between peptide growth factor and estrogen receptor signaling pathways 

    상세보기

13. Mol Cell Biol Bhat-Nakshatri 28 7487 2008 10.1128/MCB.00799-08 AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer 

    상세보기

14. Cancer Res O'Reilly 66 1500 2006 10.1158/0008-5472.CAN-05-2925 mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt 

    상세보기

15. Cancer Res Sun 65 7052 2005 10.1158/0008-5472.CAN-05-0917 Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition 

    상세보기

16. Mol Cancer Ther Davies 11 873 2012 10.1158/1535-7163.MCT-11-0824-T Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background 

    상세보기

17. Breast Cancer Res Fox 15 R55 2013 10.1186/bcr3449 Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation 

    상세보기

18. J Biol Chem Martin 278 30458 2003 10.1074/jbc.M305226200 Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation 

    상세보기

19. Endocr Relat Cancer Pancholi 15 985 2008 10.1677/ERC-07-0240 ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2 

    상세보기

20. Cancer Res Banerjee 69 4716 2009 10.1158/0008-5472.CAN-08-4711 The vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 inhibits aromatase 

    상세보기

21. Adv Enzyme Regul Chou 22 27 1984 10.1016/0065-2571(84)90007-4 Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors 

    상세보기

22. Clin Cancer Res Cottu 20 4314 2014 10.1158/1078-0432.CCR-13-3230 Acquired resistance to endocrine treatments is associated with tumor-specific molecular changes in patient-derived luminal breast cancer xenografts 

    상세보기

23. Nat Rev Cancer Ali 2 101 2002 10.1038/nrc721 Endocrine-responsive breast cancer and strategies for combating resistance 

    상세보기

24. J Biol Chem Stossi 281 16272 2006 10.1074/jbc.M513405200 Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter 

    상세보기

25. Biochem Soc Trans Martinez-Gac 32 360 2004 10.1042/bst0320360 Phosphoinositide 3-kinase and Forkhead, a switch for cell division 

    상세보기

26. Nat Chem Biol Okuzumi 5 484 2009 10.1038/nchembio.183 Inhibitor hijacking of Akt activation 

    상세보기

27. Cell Zha 87 619 1996 10.1016/S0092-8674(00)81382-3 Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) 

    상세보기

28. Sci Transl Med Bosch 7 283ra51 2015 10.1126/scitranslmed.aaa4442 PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer 

    상세보기

29. Proc Natl Acad Sci U S A Chakrabarty 109 2718 2012 10.1073/pnas.1018001108 Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors 

    상세보기

30. Cancer Cell Chandarlapaty 19 58 2011 10.1016/j.ccr.2010.10.031 AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity 

    상세보기

31. Cancer Discov Rodrik-Outmezguine 1 248 2011 10.1158/2159-8290.CD-11-0085 mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling 

    상세보기

32. Sci Signal Mounir 4 ra62 2011 10.1126/scisignal.2001630 Akt determines cell fate through inhibition of the PERK-eIF2alpha phosphorylation pathway 

    상세보기

33. Biochem J Srinivas 395 653 2006 10.1042/BJ20051794 Akt phosphorylates and suppresses the transactivation of retinoic acid receptor alpha 

    상세보기

34. Genes Dev Ross-Innes 24 171 2010 10.1101/gad.552910 Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer 

    상세보기

35. Breast Cancer Res Creighton 12 R40 2010 10.1186/bcr2594 Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer 

    상세보기

36. Mol Cell Chen 6 127 2000 10.1016/S1097-2765(05)00004-3 Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7 

    상세보기

37. Proc Natl Acad Sci U S A Bour 102 16608 2005 10.1073/pnas.0505556102 Cyclin H binding to the RARalpha activation function (AF)-2 domain directs phosphorylation of the AF-1 domain by cyclin-dependent kinase 7 

    상세보기

38. Nat Commun Johansson 4 2175 2013 10.1038/ncomms3175 Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer 

    상세보기

39. EMBO Rep Nishimoto 7 782 2006 10.1038/sj.embor.7400755 MAPK signalling: ERK5 versus ERK1/2 

    상세보기

40. Oncogene Mongroo 23 8959 2004 10.1038/sj.onc.1208112 Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer 

    상세보기

41. J Cell Sci Kimura 123 747 2010 10.1242/jcs.052498 Functional molecular imaging of ILK-mediated Akt/PKB signaling cascades and the associated role of beta-parvin 

    상세보기

42. Cell Rep Morfoisse 6 155 2014 10.1016/j.celrep.2013.12.011 Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1alpha-independent translation-mediated mechanism 

    상세보기

43. Cancer Res Balakumaran 69 7803 2009 10.1158/0008-5472.CAN-09-0910 MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy 

    상세보기